FDA kicked off the new year with three final guidance documents that it claims will speed up reviews of 510(k) and PMA submissions.
On Dec. 31, CDRH issued final versions of its “Refuse to Accept Policy for 510(k)s” guidance, “Acceptance and Filing Reviews for Premarket Approval Applications”
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?